Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, May 1, 2025 · 808,640,115 Articles · 3+ Million Readers

Scar Treatment Market Analysis and Forecast to 2030 | Asia Pacific Emerging as Fastest-Growing Market in Scar Treatment - ResearchAndMarkets.com

May 01, 2025 --

The "Scar Treatment Market: Analysis by Scar Type, Treatment Type, By End User, By Region Size and Trends - Forecast up to 2030" has been added to ResearchAndMarkets.com's offering.

The global scar treatment market is set to grow significantly, projected to reach US$52.12 billion by 2030 from US$29.45 billion in 2024. This growth is driven by the rising incidence of skin conditions, surgeries, and trauma-related scars, alongside increasing consumer demand for aesthetic improvement and non-invasive treatments such as laser therapy and topical creams.

Technological advancements in laser-based treatments and regenerative medicine are enhancing the effectiveness of scar treatments. Combination therapies and the expanding medical aesthetics industry, fueled by rising disposable incomes and better access to dermatology clinics, are further boosting the market.

Online and retail pharmacy sales also contribute to market expansion, as does social media influence on skincare trends. From 2025 to 2030, the market is expected to grow at a CAGR of 9.98%.

Market Segmentation:

Scar Type: Atrophic scars, particularly those from acne and surgery, dominate the market for treatments such as topical products and laser therapy. Stretch marks are the fastest-growing segment, influenced by pregnancy rates and obesity, with increasing consumer interest in appearance driving demand.

Treatment Type: Topical products lead the market owing to their non-invasive nature and accessibility. Meanwhile, laser therapy is set for rapid growth due to technological advancements and the increasing popularity of minimally invasive procedures.

End-user: Hospitals & clinics hold a major market share due to high patient inflow for surgical scar treatments. Dermatology & aesthetic clinics are the fastest-growing segment as consumer preference shifts towards specialized cosmetic procedures.

Region: North America leads with advanced healthcare infrastructure and heightened awareness of aesthetic treatments. The Asia Pacific region is projected for rapid growth due to increasing beauty consciousness, urbanization, and investment in healthcare.

Market Dynamics:

Growth Drivers: Rising disposable incomes are enabling greater spending on advanced skincare solutions. The influence of social media and beauty standards is also encouraging consumers to prioritize skin health.

Challenges: High costs of advanced procedures such as laser therapy pose a barrier, as these are often not covered by insurance, limiting access for many consumers.

Trends: Minimally invasive treatments like laser therapy and microneedling are gaining popularity due to their lower risk and effective outcomes. Technological advancements are further enhancing treatment precision and acceptance worldwide.

Competitive Landscape:

The global scar treatment market is characterized as moderately fragmented, with a mix of large multinational companies and smaller regional players.

Players such as Mederma (Perrigo Company Plc), Smith+Nephew, Alliance Pharmaceuticals Limited, Molnlycke Health Care AB, and Bausch Health Inc. hold a significant share of the market, particularly in terms of advanced treatments and global reach. However, the presence of numerous niche and regional players, especially in emerging markets, contributes to the market's fragmented nature.

Key players in the global scar treatment market include:

  • Smith & Nephew Plc
  • Bausch Health Companies Inc.
  • Molnlycke AB
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  • Sonoma Pharmaceuticals, Inc.
  • Perrigo Company plc
  • Alliance Pharma plc
  • Merz Pharma GmbH & Co. KGaA
  • Candela Medical
  • Cynosure
  • CCA Industries, Inc.
  • NewMedical Technology, Inc.

The key players are constantly investing in strategic initiatives, such as adoption of new technologies, introducing their products to emerging markets and more, to maintain a competitive edge in this market. For instance, In January 2024, Bausch Health announced that its Solta Medical's Thermage FLX received registration certifications in China. This non-invasive treatment uses radiofrequency technology to improve skin texture and smoothness, contributing to scar management by optimizing patients' appearances.

Key Topics Covered:

1. Executive Summary

2. Introduction

2.1 Scar Treatment: An Overview

2.2 Scar Treatment Segmentation: An Overview

3. Global Market Analysis

3.1 Global Scar Treatment Market: An Analysis

3.2 Global Scar Treatment Market: Scar Type Analysis

3.3 Global Scar Treatment Market: Treatment Type Analysis

3.4 Global Scar Treatment Market: End-user Analysis

4. Regional Market Analysis

4.1 North America Scar Treatment Market: An Analysis

4.2 Europe Scar Treatment Market: An Analysis

4.3 Asia Pacific Scar Treatment Market: An Analysis

4.4 Rest of the World Scar Treatment Market: An Analysis

5. Impact of COVID-19

6. Market Dynamics

6.1 Growth Drivers

6.1.1 Rising Disposable Income and Spending on Aesthetic Procedures

6.1.2 Growing Healthcare Expenditure

6.1.3 Rising Social Media Influence

6.1.4 Increasing Incidence of Scars Due to Surgeries and Injuries

6.1.5 Rising Prevalence of Skin Disorders

6.1.6 Growing Popularity Of Non-invasive (Minimally-invasive) Treatments

6.2 Challenges

6.2.1 High Cost of Advanced Scar Treatment Procedures

6.2.2 Regulatory Scenario

6.3 Market Trends

6.3.1 Rise in Adoption of Artificial Intelligence

6.3.2 Rising Adoption of Biologics and Regenerative Medicine

6.3.3 Growing Preference for Natural and Organic Scar Treatment Products

6.3.4 Advancements in Laser Therapy and Energy-Based Devices

6.3.5 Medical Tourism

7. Competitive Landscape

8. Company Profiles

  • Smith & Nephew
  • Bausch Health Companies Inc.
  • Business Strategy
  • Molnlycke AB
  • Business Strategy
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  • Business Strategy
  • Sonoma Pharmaceuticals, Inc.
  • Operating Regions
  • Business Strategy
  • Perrigo Company plc
  • Business Strategy
  • Alliance Pharma plc
  • Merz Pharma GmbH & Co. KGaA
  • Business Strategy
  • Candela
  • Business Strategy
  • Cynosure
  • Business Strategy
  • CCA Industries, Inc.
  • Business Strategy
  • NewMedical Technology, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/qtm827

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Powered by EIN Presswire

Distribution channels:

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release